| Actionable mutations in pancreatic cancer : where targeted therapies are making a difference | BMJ open gastroenterology |  | | 2025 | 7 | 111 |
|
| Impact of Neoadjuvant Immunotherapy in Localized Rectal Cancer. A Systematic Review | Clinical colorectal cancer | | | 2025 | 19 | 321 |
|
| Cancer du pancréas en 2025 : prise en charge multidisciplinaire | Revue médicale suisse |  | | 2025 | 53 | 0 |
|
| Neoantigen-specific T-cell response after donor lymphocyte infusion associates with favorable outcome in a patient with i(12p) germ cell tumor, acute leukemia and sarcoma of the same clonal origin | Haematologica | | | 2024 | 108 | 93 |
|
| An Overview of Cytokine Release Syndrome and Other Side Effects of CAR-T Cell Therapy | Praxis | | | 2023 | 124 | 0 |
|
| Novel pathophysiological insights into CAR-T cell associated neurotoxicity | Frontiers in neurology | | | 2023 | 174 | 266 |
|
| Challenging Hurdles of Current Targeting in Glioblastoma: A Focus on Immunotherapeutic Strategies | International Journal of Molecular Sciences | | | 2021 | 264 | 427 |
|
| Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma | Journal for immunotherapy of cancer | | | 2021 | 281 | 343 |
|
| Treating ICB-resistant glioma with anti-CD40 and mitotic spindle checkpoint controller BAL101553 (lisavanbulin) | JCI insight | | | 2021 | 266 | 352 |
|
| Improved glioblastoma mouse models to design better immunotherapeutic combinations | | | | 2019 | 655 | 198 |
|
| Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models | OncoImmunology | | | 2018 | 437 | 1 |
|
